ORBIMED ADVISORS LLC 13D/13G Filings for Ikena Oncology, Inc. (IKNA)

ORBIMED ADVISORS LLC 13D and 13G filings for Ikena Oncology, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-09-21
4:52 pm
Sale
2023-08-0413DIkena Oncology, Inc.
IKNA
ORBIMED ADVISORS LLC2,189,111
5.200%
-153,121decrease
(-6.54%)
Filing
2023-09-14
4:21 pm
Purchase
2023-08-0413DIkena Oncology, Inc.
IKNA
ORBIMED ADVISORS LLC2,342,232
5.500%
405,346increase
(+20.93%)
Filing
2021-08-16
4:45 pm
Unchanged
2021-08-1213DIkena Oncology, Inc.
IKNA
ORBIMED ADVISORS LLC1,936,886
5.400%
0
(Unchanged)
Filing
2021-04-14
7:31 pm
Purchase
2021-03-3013DIkena Oncology, Inc.
IKNA
ORBIMED ADVISORS LLC1,936,886
6.560%
1,936,886increase
(New Position)
Filing